Glimten-M2 is a combination oral antidiabetic medication that contains Glimepiride and Metformin Hydrochloride (Sustained Release). It is prescribed to help control blood sugar levels in adults with type 2 diabetes mellitus, especially when diet and exercise alone do not provide adequate glycemic control.
Uses:
Helps lower blood glucose levels by stimulating the pancreas to release insulin (Glimepiride).
Improves the body’s sensitivity to insulin and reduces glucose production in the liver (Metformin).
Used as part of a comprehensive diabetes management plan including diet and exercise.
Benefits:
Effective in managing blood sugar levels.
May help reduce the risk of diabetes-related complications such as nerve damage, kidney problems, and cardiovascular disease.
Sustained-release formulation provides a controlled release of Metformin, improving tolerability and compliance.
Dosage & Administration:
Take the tablets orally with meals as prescribed by the healthcare provider.
Do not exceed the recommended dose. Regular blood sugar monitoring is essential.
Possible Side Effects:
Gastrointestinal discomfort such as nausea, vomiting, diarrhea, or abdominal pain (usually temporary).
Hypoglycemia (low blood sugar), especially if meals are skipped or combined with other diabetes medications. Symptoms include dizziness, sweating, shakiness, and confusion.
Rarely, lactic acidosis, a serious metabolic condition – seek immediate medical help if experiencing symptoms like muscle pain, difficulty breathing, or severe weakness.
Precautions:
Inform your doctor if you have kidney or liver problems, heart disease, or any other chronic condition.
Avoid alcohol consumption during treatment.
Regular medical checkups and blood tests are advised during therapy.
